THE Vladimir Putin stated today that Russian scientists are close to creating a cancer vaccinewhich will soon be available for sufferers.
In televised remarks, Putin said that “we have arrived very close to creating so-called cancer vaccines or immunomodulatory drugs of new generation”.
“I hope they will soon be used effectively as personalized treatment methods,” he added, speaking at a forum on future technologies.
Putin it did not specify which types of cancer the vaccines would target, or how.
The pharmaceuticals that have thrown themselves into the battle for the vaccine
Several countries and pharmaceutical companies they are trying to create cancer vaccines. Last year the UK government signed a deal with Germany-based BioNTech to start clinical trials for “personalised cancer treatments”, aiming to reach 10,000 patients by 2030.
As APE-MPE notes, the pharmaceutical companies Moderna and Merck & Co are developing one experimental cancer vaccine which in mid-stage research has been shown to cut the chance of recurrence or death from melanoma – the deadliest skin cancer – in half after three years of treatment.
Right now there are six approved human papillomavirus (HPV) vaccines which causes many cancers, including cervical cancer, according to the World Health Organization (WHO), as well as hepatitis B (HBV) vaccines, which can lead to lung cancer.
During his pandemic coronavirusRussia developed its own Sputnik V vaccine against COVID-19 which it sold to some countries, although domestically it faced a general reluctance to get vaccinated.
Putin himself was inoculated with the Sputnik vaccine in an attempt to convince the world of the efficacy and safety of the formulation.
Source: News Beast
With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.
